Search research articles
Contact Us
Filters
Showing results (51-60 of 310) with videos related to
Page
of 31
Sort By:
Frontiers in Neurology
|
January 29, 2015
Changes in chronotype after stroke: a pilot study
Thomas Kantermann, Andreas Meisel, Katharina Fitzthum, et al.
Frontiers in Neurology
|
September 30, 2021
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity
Frauke Stascheit, Benjamin Hotter, Sarah Klose, et al.
Journal of Neuroimmunology
|
March 27, 2018
Immunomodulatory treatment with systemic GM-CSF augments pulmonary immune responses and improves neurological outcome after experimental stroke
Claudia Dames, Katarzyna Winek, Yasmin Beckers, et al.
Journal of Neuroimmunology
|
May 26, 2015
Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP
Juliane Klehmet, Max Staudt, Lena Ulm, et al.
Plos One
|
October 15, 2021
Cost-effectiveness of patient navigation programs for stroke patients-A systematic review
Benjamin Kass, Christina Dornquast, Andreas Meisel, et al.
Neurology and Therapy
|
May 5, 2022
The European Lambert-Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
Andreas Meisel, Jörn P Sieb, Gwendal Le Masson, et al.
Neurotoxicity Research
|
November 20, 2009
Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons
Miguel Angelo Lopes, Andreas Meisel, Félix Dias Carvalho, et al.
Cephalalgia : an International Journal of Headache
|
March 13, 2014
Anti-NMDAR encephalitis mimicking HaNDL syndrome
Carsten Finke, Annerose Mengel, Harald Prüss, et al.
European Journal of Neurology
|
June 18, 2022
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case series
Frauke Stascheit, Anne Rübsam, Carolin Otto, et al.
Brain and Behavior
|
October 27, 2016
Fatigue in myasthenia gravis: risk factors and impact on quality of life
Sarah Hoffmann, Johanna Ramm, Ulrike Grittner, et al.
Page
of 31
Search research articles
Search
Showing results (51-60 of 310) with videos related to
Sort By:
Page
of 31
Frontiers in Neurology
|
January 29, 2015
Changes in chronotype after stroke: a pilot study
Thomas Kantermann, Andreas Meisel, Katharina Fitzthum, et al.
Frontiers in Neurology
|
September 30, 2021
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity
Frauke Stascheit, Benjamin Hotter, Sarah Klose, et al.
Journal of Neuroimmunology
|
March 27, 2018
Immunomodulatory treatment with systemic GM-CSF augments pulmonary immune responses and improves neurological outcome after experimental stroke
Claudia Dames, Katarzyna Winek, Yasmin Beckers, et al.
Journal of Neuroimmunology
|
May 26, 2015
Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP
Juliane Klehmet, Max Staudt, Lena Ulm, et al.
Plos One
|
October 15, 2021
Cost-effectiveness of patient navigation programs for stroke patients-A systematic review
Benjamin Kass, Christina Dornquast, Andreas Meisel, et al.
Neurology and Therapy
|
May 5, 2022
The European Lambert-Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
Andreas Meisel, Jörn P Sieb, Gwendal Le Masson, et al.
Neurotoxicity Research
|
November 20, 2009
Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons
Miguel Angelo Lopes, Andreas Meisel, Félix Dias Carvalho, et al.
Cephalalgia : an International Journal of Headache
|
March 13, 2014
Anti-NMDAR encephalitis mimicking HaNDL syndrome
Carsten Finke, Annerose Mengel, Harald Prüss, et al.
European Journal of Neurology
|
June 18, 2022
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case series
Frauke Stascheit, Anne Rübsam, Carolin Otto, et al.
Brain and Behavior
|
October 27, 2016
Fatigue in myasthenia gravis: risk factors and impact on quality of life
Sarah Hoffmann, Johanna Ramm, Ulrike Grittner, et al.
Page
of 31